[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100571049":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":10,"centralContacts":29,"locations":10,"responsibleParty":38,"collaborators":10,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":10,"eligibilityCriteria":48,"healthyVolunteers":44,"sex":49,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":10,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":10,"overallStatus":59,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":10},{"fullName":5,"class":6},"Sohag University","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"MASLD patients with hepatic fibrosis",null,"MASLD with hepatic fibrosis with type 2 diabetes mellitus",[13,14],"Diagnostic Test: serum Adiponectine and Resistin","Diagnostic Test: fibroscan",{"label":16,"type":10,"description":17,"interventionNames":18},"MASLD without hepatic fibrosis","MASLD with out hepatic fibrosis with type 2 diabetes mellutis",[13,14],[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"DIAGNOSTIC_TEST","serum Adiponectine and Resistin","corrolation between serum adiponectin and Resistin levels and degree of hepatic fibrosis",[9,16],{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"fibroscan","hepatic fibrosis detection in type 2 diabetes mellutis",[9,16],[30,35],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"ELZAHRAA K Mohammed, spcialist","CONTACT","01064954825","elzahraaadbelrehem@sohag.edu.eg",{"name":36,"role":32,"phone":37,"phoneExt":10,"email":10},"usama M Abdelaal, professor","01065962094",{"type":39,"investigatorFullName":40,"investigatorTitle":41,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Elzahraa Kadry Mohamed","Teaching assistant fellow At sohag teaching hospital","100571049","correlation-between-serum-adiponectin-and-resistin-levels-and-degree-of-hepatic-fibrosis-in-masld-with-type2-diabetes-mellitus-100571049",false,"NCT06715189","Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus","Correlation Between Serum Adiponectin and Resistin Levels and Degree of Hepatic Fibrosis In Metabolic Dysfunction _Associated Steatotic Liver Disease (MASLD)With Type2 Diabetes Mellitus","Inclusion Criteria:\n\n* patients of both sex who have type2 Diabetes Mellitus for less than five years\n\nExclusion Criteria:alcholics ,chronic liver disease elevated liver functions , sever infection\n\n\\-","ALL","30 Years","65 Years",{"count":53,"type":54},80,"ESTIMATED","OBSERVATIONAL","Metabolic dysfunction asociated steatotic liver disease prevalence is 25%world wide diabetic patients have a risk for MASLD then have hepatic fibrosis so we study correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic fibrosis In Metabolic dysfunction asociated steatotic liver disease in patients with type2 Diabetes Mellitus",[58],"Hepatic Fibrosis","NOT_YET_RECRUITING","2024-11-28",{"date":62,"type":63},"2024-12-04","ACTUAL",{"date":65,"type":54},"2024-12-01",{"date":67,"type":54},"2025-12-30",{"name":5,"class":6}]